Beam Therapeutics Inc.
Develops precision genetic medicines using proprietary base editing technology.
BEAM | US
Overview
Corporate Details
- ISIN(s):
- US07373V1052
- LEI:
- Country:
- United States of America
- Address:
- 26 LANDSDOWNE STREET, 2139 CAMBRIDGE
- Website:
- https://beamtx.com/
- Sector:
- Manufacturing
Description
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-04 13:11 |
10-Q - Beam Therapeutics Inc. (0001745999) (Filer)
|
English | 1.9 MB | ||
| 2025-11-04 13:06 |
8-K - Beam Therapeutics Inc. (0001745999) (Filer)
|
English | 163.6 KB |
Automate Your Workflow. Get a real-time feed of all Beam Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Beam Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beam Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
